Growth Hormone
Cold Chain RequiredFDA Approved
Description
Somatropin is a recombinant human growth hormone used to treat growth failure in children with various genetic and chromosomal disorders. It has been used in patients with chromosome 1q21.1 duplication syndrome who present with growth delays and short stature. The therapy aims to normalize growth velocity and final adult height.
Indications & Therapeutic Use
Growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, short stature associated with chromosomal abnormalities
Global Availability (11 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Growth Hormone
| Generic Name | Growth Hormone |
| Brands | 1 brand available |
| Active Ingredient | Somatropin |
| Drug Class | Growth hormone deficiency |
| Manufacturer | Pfizer |
| Dosage Forms | Subcutaneous injection, 5mg, 12mg cartridges |
| Medical Code | H01AC01 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 10 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT01603095 |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes